FDA Inspection 1337438 — University Of Illinois At Chicago Andrology Laboratory
The FDA completed an inspection of University Of Illinois At Chicago Andrology Laboratory on Sep 22, 2026 in Chicago, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 22, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Chicago, IL (United States)